JohnStephenWalshMDFAAFP

Urgent Care

Attending Physician & VP Medical Affairs

Dr. Walsh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Zucker School of Medicine at Hofstra/Northwell at South Shore University HospitalResidency, Family Medicine, 1995 - 1998
St. George's University School of MedicineClass of 1995

PubMed

A Comparison of the Real-Life Clinical Effectiveness of the Leading Licensed ICS/LABA Combination Inhalers in the Treatment for COPD.
Ming SWY, Haughney J, Ryan D, Small I, Lavorini F, Papi A, Singh D, Halpin DMG, Hurst JR, Patel S, Ochel M, Kocks J, Carter V, Hardjojo A, Price DB> ;International journal of chronic obstructive pulmonary disease. 2020-11-26
37 citations
Gastrointestinal Tolerability of Delayed-Release Dimethyl Fumarate in a Multicenter, Open-Label Study of Patients with Relapsing Forms of Multiple Sclerosis (MANAGE).
Edward Fox, Alberto Vasquez, William Grainger, Tina S. Ma, Christian von Hehn, John G. Walsh, Jie Li, Javier Zambrano> ;International Journal of MS Care. 2016 Feb 26
22 citations
Customizing inhaled therapy to meet the needs of COPD patients.
Leonard Fromer, Elizabeth Goodwin, John Walsh> ;Postgraduate Medicine. 2010 Mar 1

Vice President, Medical Affairs - North America, Egetis Therapeutics2022 - Present
Senior Vice President, Ardelyx2020 - 2021
Vice President - US Medical Affairs, EMD SeronoVice President, US Medical AffairsDisclosure: employee2017 - 2020
Senior Medical Director, BiogenDisclosure: Past employee2012 - 2017
Medical Director, Sepracor/SunovionDisclosure: Past employee2008 - 2012